Abstract
Monoamine oxidase B (MAO-B) was recently identified as a member of the family of imidazoline binding proteins. To localize the imidazoline binding domain on MAO-B, we labeled the domain with the imidazoline photoaffinity adduct [125I]2-(3-azido-4-iodophenoxy)methylimidazoline in rat and human liver and visualized labeled peptides by autoradiography/sodium dodecyl sulfate-polyacrylamide gel electrophoresis after CNBr cleavage of the labeled protein. Based on species-specific fragmentation patterns and immunoprecipitation of labeled peptides, the imidazoline binding domain was localized to residues K149 to M222 of human MAO-B. The imidazoline binding domain is encompassed within a region that influences substrate processing but is distinct from primary sites of interaction for the enzyme inhibitors pargyline and lazabemide (Ro 19–6327). Radioligand binding assays and photoaffinity labeling also indicated that the various classes of compounds did not cross-compete at the different enzyme domains. Identification of an imidazoline binding domain on MAO-B provides a new opportunity for the potential pharmacological development of imidazoline/guanidinium compounds and also presents additional avenues for structure/function analysis of the monoamine oxidase enzymes.
Footnotes
- Received May 27, 1997.
- Accepted June 24, 1997.
-
Send reprint requests to: Stephen M. Lanier, Ph.D., Department of Pharmacology, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425. E-mail:laniersm{at}musc.edu
-
This work was supported by National Institutes of Health Grants NS24821 (S.M.L.) and F32-NS10332 (R.R.), Institut National de la Santé et de la Recherche Médicale Grant 910205 (A.P), and North Atlantic Treaty Organization Collaborative Research Grant CRG 951340 (A.P., S.M.L.).
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|